Etamsylate - Wikipedia
WEBEtamsylate (sometimes spelled ethamsylate) is an antihemorrhagic agent which is believed to work by increasing resistance in the endothelium of capillaries and promoting platelet adhesion. [1][2] It also inhibits biosynthesis and action of those prostaglandins which cause platelet disaggregation, vasodilation and increased capillary permeability.
Etamsylate - an overview | ScienceDirect Topics
WEBEtamsylate (formerly also known as cyclonamine) is a synthetic water-soluble non-steroidal drug (diethylamine 2,5-dihydroxybenzenesulphonate), which was shown many years ago to increase platelet adhesion to glass beads.
Etamsylate - an overview | ScienceDirect Topics
WEBAug 10, 2019 · Etamsylate (formerly also known as cyclonamine) is a synthetic water-soluble non-steroidal drug (diethylamine 2, 5-dihydroxybenzenesulphonate), which was shown many years ago to increase platelet adhesion to glass beads.
Etamsylate - Indications, Dosage, Side Effects and Precautions - Medindia
WEBAug 11, 2022 · This medication is a haemostatic agent, prescribed for the management of blood loss in menorrhagia, and after surgery. It reduces bleeding from very small blood vessels (capillaries). When should...
Etamsylate (Sylate), Mechanism of Action, Indication and Dosage
WEBAug 4, 2020 · Etamsylate is a synthetic antihaemorrhagic agent that acts on the first stage of blood clotting or hemostasis known as endothelium platelet interaction. By improving platelet adhesiveness and restoring capillary resistance, it reduces the bleeding time and blood loss. Sylate does not have a vasoconstriction effect.
Etamsylate - Wikiwand
WEBEtamsylate (sometimes spelled ethamsylate) is an antihemorrhagic agent which is believed to work by increasing resistance in the endothelium of capillaries and promoting platelet adhesion. It also inhibits biosynthesis and action of those prostaglandins which cause platelet disaggregation, vasodilation and increased capillary permeability.
止血敏是什么药物? - 百度知道
WEB[英文名]Etamsvlatum. [别名]止血定、经苯磺乙胺、Dicynone、Cyclonamine。 [分子式]C10H17O5NS. [性状]为白色结晶或结晶性粉末；无奥，味苦；有引湿性，遇光易变质。 易溶于水，溶于乙醇，微溶于丙酮，不溶于氯仿或乙醚。 [作用与用途]能增加血小板生成，增强其聚集及粘合力，促使凝血活性物质释放，缩短凝血时间，达到止血效果。 还有增强毛细血管低抗力，减少其通透性的功效。 用于防治手术前后及血管因素出血。 [用法与用量]口 …
Therapeutic efficacy and mechanism of action of ethamsylate, a …
WEBEthamsylate acts on the first step of hemostasis by improving platelet adhesiveness and restoring capillary resistance. Recent studies showed that ethamsylate promotes P-selectin-dependent, platelet adhesive mechanisms. Finally, we compare ethamsylate with other recent hemostatic agents.
止血敏|美迪医疗网
WEB药品名：止血敏Etamsvlatum. 别名：止血定、羟苯磺乙胺、酚磺乙胺、Dicynone、Cyclonamine。 性状：为白色结晶或结晶性粉末；无奥，味苦；有引湿性，遇光易变质。 易溶于水，溶于乙醇，微溶于丙酮，不溶于氯仿或乙醚。 作用与用途：能增加血小板生成，增强其聚集及粘合力，促使凝血活性物质释放，缩短凝血时间，达到止血效果。 还有增强毛细血管低抗力，减少其通透性的功效。 用于防治手术前后及血管因素出血。 用法与用量： …
Evaluation of the effect of etamsylate on thromboelastographic …
WEBSep 16, 2023 · Etamsylate (also called 2,5-dihydroxy-benzene-sulfonate diethylammonium salt or Dicynone) is a haemostatic drug used clinically to stop bleeding in animals and humans. Its mechanism of action at the haemostatic level is complex. Etamsylate reduces the synthesis of prostacyclin, thus promoting platelet aggregation (Garay et al. 2006).